You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
CPS-071 - Impact of the introduction of Generic Apixaban and Rivaroxaban: Case-study of a pharmacy in a suburban area of Lisbon, Portugal
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: CPS-071
- By: LOURENçO, Luís (CPG - Central Pharma Group, Portugal)
- Co-author(s): Luís Lourenço (CPG - Central Pharma Group, Lisboa, Portugal)
José Pais
Pedro Silva
Catarina Teodósio
Marta Lopes
Abdelhak Lemsaddek - Abstract:
Introduction
The introduction of generic drugs into the pharmaceutical market has a significant impact on the sales of brand-name medications. Generics are more affordable versions of original drugs, containing the same active substance, dosage, and pharmaceutical form, being commercialized after the expiration of the reference drug’s patent... The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026